Laser Hair Growth System, Hair Regrowth Helmet & Laser Cap (FDA Cleared), Hair Loss Treatment for Men and Women, Low Level Laser Therapy for Hair Growth, Anti-Thining Treatment Pink, 36 Air

About This Product :

• THE LLLT: It has long been know that infrared laser light promotes tissue repair and regeneration, as well as the low-level laser therapy (LLLT). hair growth devices have been developed for scalp care and hair regrowth since 2017, via emitting the 650nm 5mW infrared laser penetrates to the hair follicle-which is 3-5mm under the surface of the scalp, it generating many kinds of energy, stimulating the growth factors, accelerating blood circulation and the metabolism of hair follicle.
• UNIQUE TECHNOLOGY: originally created laser matrix technology(Lmatrix) and automatic stable energy system(ASE). Combined Lmatrix with helmet’s head fit design, provides a more uniform and larger coverage of illumination, which is more effective than traditional combs and bands. ASE system can stabilize the output power of infrared laser within most effective treatment range of 5mW, which improves the energy stability and utilization rate by 30% compared with similar products.
• GUARANTEE: provides 6-month full refund of ineffective, 1-year free replacement service for product quality defects. For most of the hair loss patients in the world, our products can control oil within 1 month, stop hair loss within 2 months, help hair regrowth within 3-6 months, and significantly increase hair volume after 6 months. Support Service is always here.
• FDA CLAEARED: has been certified by both the United State FDA and China CFDA, which own the first smart hair growth device around the world. In the up to 2 years’ clinical experiment, the effective rate of hair regrowth up to 90%, can 100% help people away from normal hair loss. Published in SPRINGER NATURE 2022, the article of LLLT’s treatment of androgenetic alopecia, which depends on the ’s real world study, also prove the efficacy of products.
• COMPATIBILITY: LLLT appears to improve a variety of non-scarring alopecia—Androgenetic Alopecia (AGA), Alopecia Areata (AA), chemotherapy-induced alopecia and postpartum hair loss etc. Since LLLT has no side effects, and combined with the research of its effects on promoting graft survival, we suggest that devices can be used in conjunction with other means of preventing hair loss, such as drug treatment and hair transplantation, the effect will be more significant.